Live feed16:28:00·581dINSIDERFilingvia QuantisnowDirector Pande Vijay Satyanand converted options into 2,113,975 shares and bought $16,200,000 worth of shares (900,000 units at $18.00) (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.BIOA· BioAge Labs Inc.Health CareOriginal source
